RTTNews | Oct 22, 2020 06:10AM EDT

06:10 Thursday, October 22, 2020 (RTTNews.com) - While reporting financial results for the third quarter on Thursday, medical company Danaher Corp. (DHR) said it anticipates adjusted core revenue growth for the fourth quarter, including Cytiva, to be in the low-double digit range.

On average, analysts polled by Thomson Reuters expect the company to report revenue growth of 27.1 percent to $6.19 billion or the quarter.

Read the original article on RTTNews ( https://www.rttnews.com/3138329/danaher-guides-q4-revenue-growth-below-estimates-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved